{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T07:47:15Z","timestamp":1771660035817,"version":"3.50.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T00:00:00Z","timestamp":1448409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T00:00:00Z","timestamp":1448409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A poliomyelitis outbreak caused by type 1 circulating vaccine-derived polioviruses (cVDPVs) was identified in China in 2004. Six independent cVDPVs (eight isolates) could be grouped into a single cluster with pathways of divergence different from a single cVDPV progenitor, which circulated and evolved into both a highly neurovirulent lineage and a less neurovirulent lineage. They were as neurovirulent as the wild type 1 Mahoney strain, recombination was absent and their nucleotide 480-G was identical to that of the Sabin strain. The Guizhou\/China cVDPV strains shared 4 amino acid replacements in the NAg sites: 3 located at the BC loop, which may underlie the aberrant results of the ELISA intratypic differentiation (ITD) test. The complete ORF tree diverged into two main branches from a common ancestral infection estimated to have occurred in about mid-September 2003, nine months before the appearance of the VDPV case, which indicated recently evolved VDPV. Further, recombination with species C enteroviruses may indicate the presence and density of these enteroviruses in the population and prolonged virus circulation in the community. The aforementioned cVDPVs has important implications in the global initiative to eradicate polio: high quality surveillance permitted earliest detection and response.<\/jats:p>","DOI":"10.1038\/srep17291","type":"journal-article","created":{"date-parts":[[2015,11,25]],"date-time":"2015-11-25T10:11:12Z","timestamp":1448446272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["An Insight into Recombination with Enterovirus Species C and Nucleotide G-480 Reversion from the Viewpoint of Neurovirulence of Vaccine-Derived Polioviruses"],"prefix":"10.1038","volume":"5","author":[{"given":"Yong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongmei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yorihiro","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xufang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaume","family":"Jorba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongqiu","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olen","family":"Kew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenbo","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,25]]},"reference":[{"key":"BFsrep17291_CR1","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1073\/pnas.89.7.2531","volume":"89","author":"JC De la Torre","year":"1992","unstructured":"De la Torre, J. C., Giachetti, C., Semler, B. L. & Holland, J. J. High frequency of single-base transitions and extreme frequency of precise multiple-base reversion mutations in poliovirus. Proc Natl Acad Sci USA 89, 2531\u20135 (1992).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep17291_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1099\/0022-1317-56-2-337","volume":"56","author":"OM Kew","year":"1981","unstructured":"Kew, O. M., Nottay, B. K., Hatch, M. H., Nakano, J. H. & Obijeski, J. F. Multiple genetic changes can occur in the oral poliovaccines upon replication in humans. J Gen Virol 56, 337\u201347 (1981).","journal-title":"J Gen Virol"},{"key":"BFsrep17291_CR3","doi-asserted-by":"publisher","first-page":"11153","DOI":"10.1128\/JVI.74.23.11153-11161.2000","volume":"74","author":"HM Liu","year":"2000","unstructured":"Liu, H. M. et al. Molecular evolution of a type 1 wild-vaccine poliovirus recombinant during widespread circulation in China. J Virol 74, 11153\u201361 (2000).","journal-title":"J Virol"},{"key":"BFsrep17291_CR4","doi-asserted-by":"publisher","first-page":"e15300","DOI":"10.1371\/journal.pone.0015300","volume":"5","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. Natural type 3\/type 2 intertypic vaccine-related poliovirus recombinants with the first crossover sites within the VP1 capsid coding region. PLoS ONE 5, e15300 (2010).","journal-title":"PLoS ONE"},{"key":"BFsrep17291_CR5","doi-asserted-by":"publisher","first-page":"S283","DOI":"10.1093\/infdis\/jiu295","volume":"210","author":"CC Burns","year":"2014","unstructured":"Burns, C. C., Diop, O. M., Sutter, R. W. & Kew, O. M. Vaccine-derived polioviruses. J Infect Dis 210 Suppl 1, S283\u201393 (2014).","journal-title":"J Infect Dis"},{"key":"BFsrep17291_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1146\/annurev.micro.58.030603.123625","volume":"59","author":"OM Kew","year":"2005","unstructured":"Kew, O. M., Sutter, R. W., de Gourville, E. M., Dowdle, W. R. & Pallansch, M. A. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annu Rev Microbiol 59, 587\u2013635 (2005).","journal-title":"Annu Rev Microbiol"},{"key":"BFsrep17291_CR7","first-page":"16","volume":"82","author":"OM Kew","year":"2004","unstructured":"Kew, O. M. et al. Circulating vaccine-derived polioviruses: current state of knowledge. Bull World Health Organ 82, 16\u201323 (2004).","journal-title":"Bull World Health Organ"},{"key":"BFsrep17291_CR8","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1126\/science.1068284","volume":"296","author":"O Kew","year":"2002","unstructured":"Kew, O. et al. Outbreak of poliomyelitis in Hispaniola associated with circulating type 1 vaccine-derived poliovirus. Science 296, 356\u20139 (2002).","journal-title":"Science"},{"key":"BFsrep17291_CR9","doi-asserted-by":"publisher","first-page":"13512","DOI":"10.1128\/JVI.78.24.13512-13521.2004","volume":"78","author":"H Shimizu","year":"2004","unstructured":"Shimizu, H. et al. Circulation of type 1 vaccine-derived poliovirus in the Philippines in 2001. J Virol 78, 13512\u201321 (2004).","journal-title":"J Virol"},{"key":"BFsrep17291_CR10","doi-asserted-by":"publisher","first-page":"8366","DOI":"10.1128\/JVI.77.15.8366-8377.2003","volume":"77","author":"CF Yang","year":"2003","unstructured":"Yang, C. F. et al. Circulation of endemic type 2 vaccine-derived poliovirus in Egypt from 1983 to 1993. J Virol 77, 8366\u201377 (2003).","journal-title":"J Virol"},{"key":"BFsrep17291_CR11","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1086\/587694","volume":"197","author":"M Rakoto-Andrianarivelo","year":"2008","unstructured":"Rakoto-Andrianarivelo, M. et al. Reemergence of recombinant vaccine-derived poliovirus outbreak in Madagascar. J Infect Dis 197, 1427\u201335 (2008).","journal-title":"J Infect Dis"},{"key":"BFsrep17291_CR12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.3201\/eid0907.020692","volume":"9","author":"D Rousset","year":"2003","unstructured":"Rousset, D. et al. Recombinant vaccine-derived poliovirus in Madagascar. Emerg Infect Dis 9, 885\u20137 (2003).","journal-title":"Emerg Infect Dis"},{"key":"BFsrep17291_CR13","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1093\/infdis\/jis204","volume":"205","author":"ML Joffret","year":"2012","unstructured":"Joffret, M. L. et al. Common and diverse features of cocirculating type 2 and 3 recombinant vaccine-derived polioviruses isolated from patients with poliomyelitis and healthy children. J Infect Dis 205, 1363\u201373 (2012).","journal-title":"J Infect Dis"},{"key":"BFsrep17291_CR14","doi-asserted-by":"publisher","first-page":"3274","DOI":"10.1128\/JCM.00712-10","volume":"48","author":"D Yan","year":"2010","unstructured":"Yan, D. et al. Emergence and localized circulation of a vaccine-derived poliovirus in an isolated mountain community in Guangxi, China. J Clin Microbiol 48, 3274\u201380 (2010).","journal-title":"J Clin Microbiol"},{"key":"BFsrep17291_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1086\/506359","volume":"194","author":"X Liang","year":"2006","unstructured":"Liang, X. et al. An outbreak of poliomyelitis caused by type 1 vaccine-derived poliovirus in China. J Infect Dis 194, 545\u201351 (2006).","journal-title":"J Infect Dis"},{"key":"BFsrep17291_CR16","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1128\/CVI.00196-14","volume":"21","author":"D Yan","year":"2014","unstructured":"Yan, D. et al. Limited and localized outbreak of newly emergent type 2 vaccine-derived poliovirus in Sichuan, China. Clin Vaccine Immunol 21, 1012\u20138 (2014).","journal-title":"Clin Vaccine Immunol"},{"key":"BFsrep17291_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1086\/525049","volume":"197","author":"CF Estivariz","year":"2008","unstructured":"Estivariz, C. F. et al. A large vaccine-derived poliovirus outbreak on Madura Island\u2014Indonesia, 2005. J Infect Dis 197, 347\u201354 (2008).","journal-title":"J Infect Dis"},{"key":"BFsrep17291_CR18","doi-asserted-by":"publisher","first-page":"e3433","DOI":"10.1371\/journal.pone.0003433","volume":"3","author":"A Wringe","year":"2008","unstructured":"Wringe, A., Fine, P. E., Sutter, R. W. & Kew, O. M. Estimating the extent of vaccine-derived poliovirus infection. PLoS ONE 3, e3433 (2008).","journal-title":"PLoS ONE"},{"key":"BFsrep17291_CR19","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1093\/infdis\/jiq140","volume":"203","author":"S Wassilak","year":"2011","unstructured":"Wassilak, S. et al. Outbreak of type 2 vaccine-derived poliovirus in Nigeria: emergence and widespread circulation in an underimmunized population. J Infect Dis 203, 898\u2013909 (2011).","journal-title":"J Infect Dis"},{"key":"BFsrep17291_CR20","doi-asserted-by":"publisher","first-page":"2360","DOI":"10.1056\/NEJMoa0910074","volume":"362","author":"HE Jenkins","year":"2010","unstructured":"Jenkins, H. E. et al. Implications of a circulating vaccine-derived poliovirus in Nigeria. N Engl J Med 362, 2360\u20139 (2010).","journal-title":"N Engl J Med"},{"key":"BFsrep17291_CR21","doi-asserted-by":"publisher","first-page":"e88442","DOI":"10.1371\/journal.pone.0088442","volume":"9","author":"S Sharif","year":"2014","unstructured":"Sharif, S. et al. Evolution and circulation of type-2 vaccine-derived polioviruses in Nad Ali district of Southern Afghanistan during June 2009-February 2011. PLoS One 9, e88442 (2014).","journal-title":"PLoS One"},{"key":"BFsrep17291_CR22","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1016\/j.vaccine.2009.02.071","volume":"27","author":"P Minor","year":"2009","unstructured":"Minor, P. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication. Vaccine 27, 2649\u201352 (2009).","journal-title":"Vaccine"},{"key":"BFsrep17291_CR23","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1086\/657410","volume":"202","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. Type 2 vaccine-derived poliovirus from patients with acute flaccid paralysis in china: current immunization strategy effectively prevented its sustained transmission. J Infect Dis 202, 1780\u20138 (2010).","journal-title":"J Infect Dis"},{"key":"BFsrep17291_CR24","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.1128\/JVI.76.11.5339-5349.2002","volume":"76","author":"J Martin","year":"2002","unstructured":"Martin, J. & Minor, P. D. Characterization of CHAT and Cox type 1 live-attenuated poliovirus vaccine strains. J Virol 76, 5339\u201349 (2002).","journal-title":"J Virol"},{"key":"BFsrep17291_CR25","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1128\/jvi.64.10.4922-4929.1990","volume":"64","author":"C Christodoulou","year":"1990","unstructured":"Christodoulou, C. et al. Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J Virol 64, 4922\u20139 (1990).","journal-title":"J Virol"},{"key":"BFsrep17291_CR26","first-page":"17","volume":"78","author":"PD Minor","year":"1993","unstructured":"Minor, P. D. Attenuation and reversion of the Sabin vaccine strains of poliovirus. Dev Biol Stand 78, 17\u201326 (1993).","journal-title":"Dev Biol Stand"},{"key":"BFsrep17291_CR27","doi-asserted-by":"publisher","first-page":"14235","DOI":"10.1128\/JVI.79.22.14235-14243.2005","volume":"79","author":"N De Jesus","year":"2005","unstructured":"De Jesus, N., Franco, D., Paul, A., Wimmer, E. & Cello, J. Mutation of a single conserved nucleotide between the cloverleaf and internal ribosome entry site attenuates poliovirus neurovirulence. J Virol 79, 14235\u201343 (2005).","journal-title":"J Virol"},{"key":"BFsrep17291_CR28","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1128\/JVI.73.2.958-964.1999","volume":"73","author":"M Gromeier","year":"1999","unstructured":"Gromeier, M., Bossert, B., Arita, M., Nomoto, A. & Wimmer, E. Dual stem loops within the poliovirus internal ribosomal entry site control neurovirulence. J Virol 73, 958\u201364 (1999).","journal-title":"J Virol"},{"key":"BFsrep17291_CR29","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1099\/0022-1317-67-7-1283","volume":"67","author":"PD Minor","year":"1986","unstructured":"Minor, P. D., Ferguson, M., Evans, D. M., Almond, J. W. & Icenogle, J. P. Antigenic structure of polioviruses of serotypes 1, 2 and 3. J Gen Virol 67, 1283\u201391 (1986).","journal-title":"J Gen Virol"},{"key":"BFsrep17291_CR30","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1128\/jvi.66.7.4597-4600.1992","volume":"66","author":"K Wiegers","year":"1992","unstructured":"Wiegers, K. & Dernick, R. Molecular basis of antigenic structures of poliovirus: implications for their evolution during morphogenesis. J Virol 66, 4597\u2013600 (1992).","journal-title":"J Virol"},{"key":"BFsrep17291_CR31","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1093\/protein\/7.1.47","volume":"7","author":"HJ Stirk","year":"1994","unstructured":"Stirk, H. J. & Thornton, J. M. The BC loop in poliovirus coat protein VP1: an ideal acceptor site for major insertions. Protein Eng 7, 47\u201356 (1994).","journal-title":"Protein Eng"},{"key":"BFsrep17291_CR32","doi-asserted-by":"publisher","first-page":"12623","DOI":"10.1128\/JVI.79.20.12623-12634.2005","volume":"79","author":"CF Yang","year":"2005","unstructured":"Yang, C. F. et al. Intratypic recombination among lineages of type 1 vaccine-derived poliovirus emerging during chronic infection of an immunodeficient patient. J Virol 79, 12623\u201334 (2005).","journal-title":"J Virol"},{"key":"BFsrep17291_CR33","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1128\/JVI.02354-07","volume":"82","author":"J Jorba","year":"2008","unstructured":"Jorba, J., Campagnoli, R., De, L. & Kew, O. Calibration of multiple poliovirus molecular clocks covering an extended evolutionary range. J Virol 82, 4429\u201340 (2008).","journal-title":"J Virol"},{"key":"BFsrep17291_CR34","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1006\/viro.1995.1030","volume":"206","author":"S Abe","year":"1995","unstructured":"Abe, S. et al. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice. Virology 206, 1075\u201383 (1995).","journal-title":"Virology"},{"key":"BFsrep17291_CR35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1128\/jvi.68.2.681-688.1994","volume":"68","author":"H Horie","year":"1994","unstructured":"Horie, H. et al. Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence. J Virol 68, 681\u20138 (1994).","journal-title":"J Virol"},{"key":"BFsrep17291_CR36","first-page":"51","volume":"105","author":"S Ohka","year":"2001","unstructured":"Ohka, S. & Nomoto, A. The molecular basis of poliovirus neurovirulence. Dev Biol (Basel) 105, 51\u20138 (2001).","journal-title":"Dev Biol (Basel)"},{"key":"BFsrep17291_CR37","doi-asserted-by":"crossref","first-page":"4972","DOI":"10.1128\/jvi.69.8.4972-4978.1995","volume":"69","author":"MJ Bouchard","year":"1995","unstructured":"Bouchard, M. J., Lam, D. H. & Racaniello, V. R. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J Virol 69, 4972\u20138 (1995).","journal-title":"J Virol"},{"key":"BFsrep17291_CR38","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1016\/S0264-410X(98)00079-6","volume":"16","author":"C Chezzi","year":"1998","unstructured":"Chezzi, C. et al. Genetic stability of oral polio vaccine prepared on primary monkey kidney cells or Vero cells\u2014effects of passage in cell culture and the human gastrointestinal tract. Vaccine 16, 2031\u20138 (1998).","journal-title":"Vaccine"},{"key":"BFsrep17291_CR39","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1006\/viro.1998.9191","volume":"245","author":"GV Rezapkin","year":"1998","unstructured":"Rezapkin, G. V. et al. Genetic stability of Sabin 1 strain of poliovirus: implications for quality control of oral poliovirus vaccine. Virology 245, 183\u20137 (1998).","journal-title":"Virology"},{"key":"BFsrep17291_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S1045-1056(05)80003-X","volume":"20","author":"G Contreras","year":"1992","unstructured":"Contreras, G. et al. Genetic characterization of Sabin types 1 and 3 poliovaccine virus following serial passage in the human intestinal tract. Biologicals 20, 15\u201326 (1992).","journal-title":"Biologicals"},{"key":"BFsrep17291_CR41","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/jmv.20250","volume":"75","author":"PD Minor","year":"2005","unstructured":"Minor, P. D., Dunn, G., Ramsay, M. E. & Brown, D. Effect of different immunisation schedules on the excretion and reversion of oral poliovaccine strains. J Med Virol 75, 153\u201360 (2005).","journal-title":"J Med Virol"},{"key":"BFsrep17291_CR42","doi-asserted-by":"publisher","first-page":"9179","DOI":"10.1128\/JVI.00468-08","volume":"82","author":"JK Odoom","year":"2008","unstructured":"Odoom, J. K., Yunus, Z., Dunn, G., Minor, P. D. & Martin, J. Changes in population dynamics during long-term evolution of sabin type 1 poliovirus in an immunodeficient patient. J Virol 82, 9179\u201390 (2008).","journal-title":"J Virol"},{"key":"BFsrep17291_CR43","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1002\/jmv.23242","volume":"84","author":"LN Apostol","year":"2012","unstructured":"Apostol, L. N. et al. Detection of non-polio enteroviruses from 17 years of virological surveillance of acute flaccid paralysis in the Philippines. J Med Virol 84, 624\u201331 (2012).","journal-title":"J Med Virol"},{"key":"BFsrep17291_CR44","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1128\/JCM.43.1.242-249.2005","volume":"43","author":"M Rakoto-Andrianarivelo","year":"2005","unstructured":"Rakoto-Andrianarivelo, M. et al. High frequency of human enterovirus species C circulation in Madagascar. J Clin Microbiol 43, 242\u20139 (2005).","journal-title":"J Clin Microbiol"},{"key":"BFsrep17291_CR45","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1371\/journal.ppat.0030191","volume":"3","author":"M Rakoto-Andrianarivelo","year":"2007","unstructured":"Rakoto-Andrianarivelo, M. et al. Co-circulation and evolution of polioviruses and species C enteroviruses in a district of Madagascar. PLoS Pathog 3, e191 (2007).","journal-title":"PLoS Pathog"},{"key":"BFsrep17291_CR46","doi-asserted-by":"publisher","first-page":"12650","DOI":"10.1128\/JVI.79.20.12650-12657.2005","volume":"79","author":"M Arita","year":"2005","unstructured":"Arita, M. et al. A Sabin 3-derived poliovirus recombinant contained a sequence homologous with indigenous human enterovirus species C in the viral polymerase coding region. J Virol 79, 12650\u20137 (2005).","journal-title":"J Virol"},{"key":"BFsrep17291_CR47","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1007\/s00705-014-2322-x","volume":"160","author":"JA Adeniji","year":"2015","unstructured":"Adeniji, J. A. & Faleye, T. O. Enterovirus C strains circulating in Nigeria and their contribution to the emergence of recombinant circulating vaccine-derived polioviruses. Arch Virol 160, 675\u201383 (2015).","journal-title":"Arch Virol"},{"key":"BFsrep17291_CR48","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s00705-009-0564-9","volume":"155","author":"Y Zhang","year":"2010","unstructured":"Zhang, Y. et al. A Sabin 2-related poliovirus recombinant contains a homologous sequence of human enterovirus species C in the viral polymerase coding region. Arch Virol 155, 197\u2013205 (2010).","journal-title":"Arch Virol"},{"key":"BFsrep17291_CR49","unstructured":"Isolation and identification of polioviruses. WHO Polio laboratory manual, 4th edn. (World Health Organization, Geneva, 2004)."},{"key":"BFsrep17291_CR50","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1093\/molbev\/msr121","volume":"28","author":"K Tamura","year":"2011","unstructured":"Tamura, K. et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance and maximum parsimony methods. Mol Biol Evol 28, 2731\u20139 (2011).","journal-title":"Mol Biol Evol"},{"key":"BFsrep17291_CR51","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/1471-2148-7-214","volume":"7","author":"AJ Drummond","year":"2007","unstructured":"Drummond, A. J. & Rambaut, A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7, 214 (2007).","journal-title":"BMC Evol Biol"},{"key":"BFsrep17291_CR52","doi-asserted-by":"publisher","first-page":"5318","DOI":"10.1093\/nar\/26.23.5318","volume":"26","author":"SR Stewart","year":"1998","unstructured":"Stewart, S. R. & Semler, B. L. RNA structure adjacent to the attenuation determinant in the 5\u2032-non-coding region influences poliovirus viability. Nucleic Acids Res 26, 5318\u201326 (1998).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep17291_CR53","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1471-2105-11-129","volume":"11","author":"JS Reuter","year":"2010","unstructured":"Reuter, J. S. & Mathews, D. H. RNAstructure: software for RNA secondary structure prediction and analysis. BMC Bioinformatics 11, 129 (2010).","journal-title":"BMC Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep17291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep17291","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep17291.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T19:47:52Z","timestamp":1672948072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep17291"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,25]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,22]]}},"alternative-id":["BFsrep17291"],"URL":"https:\/\/doi.org\/10.1038\/srep17291","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,25]]},"assertion":[{"value":"26 August 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17291"}}